Lorcaserin Extended-Release Tablets and Novo-Clavamoxin 250
Determining the interaction of Lorcaserin Extended-Release Tablets and Novo-Clavamoxin 250 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: amoxicillin / clavulanate
Brand name: Augmentin, Augmentin ES-600, Augmentin XR
Synonyms: Amoxicillin and Clavulanate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Novo-Furan Suspension
- Lorcaserin Extended-Release Tablets-Novo-Hydrocort Cream Topical application
- Lorcaserin Extended-Release Tablets-Novo-Hydrocort Topical application
- Lorcaserin Extended-Release Tablets-Novo-Lexin
- Lorcaserin Extended-Release Tablets-Novo-Methacin Suppositories
- Lorcaserin Extended-Release Tablets-Novo-Peridol
- Novo-Clavamoxin 250-Lorcaserin Hydrochloride
- Novo-Clavamoxin 250-Lorcaserin Tablets
- Novo-Clavamoxin 250-Lorcet
- Novo-Clavamoxin 250-Lorcet Plus
- Novo-Clavamoxin 250-Lorcet Tablets
- Novo-Clavamoxin 250-Lorlatinib